idb 1031 has been researched along with interleukin-8 in 1 studies
| Studies (idb 1031) | Trials (idb 1031) | Recent Studies (post-2010) (idb 1031) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballabio, P; De Amici, M; Gorrini, M; Luisetti, M; Malandrino, S; Marena, C; Meloni, F | 1 |
1 other study(ies) available for idb 1031 and interleukin-8
| Article | Year |
|---|---|
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products.
Topics: Antioxidants; Dose-Response Relationship, Drug; Flavonoids; Humans; Interleukin-8; Leukocyte Elastase; Lipopolysaccharides; Osmolar Concentration; Pancreatic Elastase; Peroxidase; Phagocytes; Tumor Necrosis Factor-alpha | 1995 |